William Eberley is an Executive Director of MSAT Process Science at Vertex Pharmaceuticals, a position held since 2025. Previously, William served as Director of MSAT in Cell and Gene Therapy at Vertex from 2022 to 2024 and held various roles at Bristol-Myers Squibb and Sanofi. William began their career with a BS and MS from The Ohio State University, supplemented by research and teaching assistant positions during their studies. Their extensive experience in the biotech industry spans roles in process engineering, manufacturing science, and cell and gene therapies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices